There are 3 PARP inhibitors that are FDA approved in multiple settings of ovarian cancer.
Justin (JC) Liauw, PharmD, BCOP
Advertisement
Articles by Justin (JC) Liauw, PharmD, BCOP
New potential medications may continue to expand the role of targeted agents.
Advertisement
Latest Updated Articles
Overview of PARP Inhibitors in the Treatment of Ovarian CancerPublished: October 11th 2021 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
Amivantamab for EGFR-Mutated Metastatic Non–Small Cell Lung Cancer
2
Celebrating the Pharmacist’s Impact: How Pharmacists Elevate Care in Every Setting
3
FDA Approves 1-Minute HIV Self-Test
4
How Pharmacists Can Navigate Legal Complexities With Most Favored Nation Status
5
